SCHEMBL13545962

SCHEMBL13545962

N#Cc1ccc(Oc2nc(-c3cccs3)cc(-c3ccco3)c2C#N)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 7/20 0.64
▸ ADORA1 P30542 7/20 0.64
▸ ADORA2B P29275 4/20 0.64
▸ TOP1 P11387 1/20 0.51
▸ KDM4E B2RXH2 8/20 0.50
▸ ALDH1A1 P00352 6/20 0.50
▸ HPGD P15428 5/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ MAPT P10636 6/20 0.46
▸ GAA P10253 5/20 0.46
▸ GLA P06280 3/20 0.46
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ PIM1 P11309 1/20 0.44
▸ POLB P06746 4/20 0.43
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ PSMD14 O00487 1/20 0.41
▸ USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14391000 0.89 ADORA2A (0.60) ADORA2AADORA1ADORA2BTOP1KDM4E
SCHEMBL13545963 0.84 ALDH1A1 (0.50) ADORA2AADORA1ADORA2BKDM4EALDH1A1
SCHEMBL3587811 0.83 ADORA2A (0.57) ADORA2AADORA1ADORA2BTOP1KDM4E
SCHEMBL5593424 0.81 ADORA1 (0.66) ADORA2AADORA1ADORA2BTOP1KDM4E
SCHEMBL3581759 0.81 ADORA2A (0.55) ADORA2AADORA1ADORA2BTOP1KDM4E
SCHEMBL3581858 0.78 ADORA2A (0.74) ADORA2AADORA1ADORA2BTOP1KDM4E
SCHEMBL5320925 0.78 ADORA2A (0.74) ADORA2AADORA1ADORA2BTOP1KDM4E
SCHEMBL13545961 0.77 ADORA2A (0.60) ADORA2AADORA1ADORA2BTOP1KDM4E
SCHEMBL13545954 0.77 ADORA2A (0.59) ADORA2AADORA1ADORA2BTOP1KDM4E
SCHEMBL14391010 0.76 ALDH1A1 (0.43) ADORA2AADORA1ADORA2BTOP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100009973-A1 Integrase Inhibitors 3 AVEXA LIMITED (AU) 2010-01-14 — — US disclosed
US-20100009973-A1 Integrase Inhibitors 3 AVEXA LIMITED (AU) 2010-01-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009973-A1 Integrase Inhibitors 3 TYMP, IMPDH1, IMPDH2 ADORA2A 3605/4885ADORA1 2470/4885ADORA2B 3500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback